Recruiting NCT06409052
Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Qualitative interviews.
- Who it may be relevant to
- Registry conditions: Endometrial Cancer. Basic parameters: from 18 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
To learn more about women's attitudes toward and knowledge about endometrial cancer and options that might decrease the risk of developing
Detailed description
To obtain pilot data regarding women's attitudes and perspectives about endometrial cancer and potential endometrial cancer prevention strategies.
Interventions
- Behavioral Qualitative interviews
Interviews will be conducted for approximately 45-60 minutes
Primary outcome measures
- Patient education [Time frame: Through study completion; an average of 1 year.]
Eligibility criteria
Inclusion criteria
- Women who present to MD Anderson Cancer Center including MDA Houston Area Locations with a diagnosis of endometrial cancer
- Women who present to MD Anderson Cancer Center including MDA Houston Area Locations with a diagnosis of abnormal uterine bleeding or endometrial hyperplasia
- Women without a diagnosis of endometrial cancer or endometrial hyperplasia
- Women must be at least 18 years or age
- Women must be able to read, write, and speak English
- Women must be willing and able to provide written informed consent
Exclusion criteria
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Other
Study locations
United States · 1 center
- MD Anderson Cancer Center — Houston
Identifiers
NCT: NCT06409052 · 2023-0443 · NCI-2023-08979